Bristol Myers Squibb (CELG-RI) FCF Margin (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has 18 years of FCF Margin data on file, last reported at 6.59% in Q1 2026.

• FCF Margin for Q1 2026 came in at 6.59%, down 853.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 24.56% (down 291.0% YoY), and the FY2025 annual result was 26.65%, down 221.0% from the prior year.
• FCF Margin declined to 6.59% in Q1 2026 per CELG-RI's latest filing, from 12.83% in the prior quarter.
• Over five years, FCF Margin peaked at 49.02% in Q3 2025 and troughed at 6.59% in Q1 2026.
• A 5-year average of 26.16% and a median of 25.95% in 2022 frame the typical range for FCF Margin.
• On a YoY basis, FCF Margin climbed as much as 1207 bps in 2025 and fell as far as 2007 bps in 2025.
• A 5-year view of FCF Margin shows it stood at 25.95% in 2022, then surged by 32 bps to 34.17% in 2023, then decreased by 4 bps to 32.9% in 2024, then plunged by 61 bps to 12.83% in 2025, then tumbled by 49 bps to 6.59% in 2026.
• Business Quant data shows CELG-RI's FCF Margin at 6.59% in Q1 2026, 12.83% in Q4 2025, and 49.02% in Q3 2025.